Abstract
QUESTION: A few women have asked me whether finasteride, taken by their partners for male pattern baldness, will affect their pregnancies. The product monograph is very alarming: it sounds as if even handling the medication could cause harm, especially to a male fetus. Should a man stop taking finasteride if his partner is planning pregnancy or is pregnant? What is the risk to the fetus if its mother accidentally handles crushed or broken tablets? ANSWER: To date, there are no reports of adverse pregnancy outcomes among women exposed to finasteride. Taking 1 mg of finasteride daily did not have any clinically significant effect on men's semen. Absorption through the skin while handling tablets is extremely unlikely to cause fetal exposure or harm. There is no reason to discontinue the drug. Motherisk is currently following up women who are pregnant or planning pregnancy and whose partners are taking finasteride.
Full Text
The Full Text of this article is available as a PDF (100.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Amichai B., Grunwald M. H., Sobel R. 5 alpha-reductase inhibitors--a new hope in dermatology? Int J Dermatol. 1997 Mar;36(3):182–184. doi: 10.1046/j.1365-4362.1997.00191.x. [DOI] [PubMed] [Google Scholar]
- Cather J. C., Lane D., Heaphy M. R., Jr, Nelson B. R. Finasteride--an update and review. Cutis. 1999 Sep;64(3):167–172. [PubMed] [Google Scholar]
- Imperato-McGinley J., Guerrero L., Gautier T., Peterson R. E. Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science. 1974 Dec 27;186(4170):1213–1215. doi: 10.1126/science.186.4170.1213. [DOI] [PubMed] [Google Scholar]
- Ivarsson S. A., Nielsen M. D., Lindberg T. Male pseudohermaphroditism due to 5 alpha-reductase deficiency in a Swedish family. Eur J Pediatr. 1988 Jun;147(5):532–535. doi: 10.1007/BF00441984. [DOI] [PubMed] [Google Scholar]
- Katz M. D., Kligman I., Cai L. Q., Zhu Y. S., Fratianni C. M., Zervoudakis I., Rosenwaks Z., Imperato-McGinley J. Paternity by intrauterine insemination with sperm from a man with 5alpha-reductase-2 deficiency. N Engl J Med. 1997 Apr 3;336(14):994–997. doi: 10.1056/NEJM199704033361404. [DOI] [PubMed] [Google Scholar]
- Moghetti P., Castello R., Magnani C. M., Tosi F., Negri C., Armanini D., Bellotti G., Muggeo M. Clinical and hormonal effects of the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism. J Clin Endocrinol Metab. 1994 Oct;79(4):1115–1121. doi: 10.1210/jcem.79.4.7962284. [DOI] [PubMed] [Google Scholar]
- Mowszowicz I., Melanitou E., Doukani A., Wright F., Kuttenn F., Mauvais-Jarvis P. Androgen binding capacity and 5 alpha-reductase activity in pubic skin fibroblasts from hirsute patients. J Clin Endocrinol Metab. 1983 Jun;56(6):1209–1213. doi: 10.1210/jcem-56-6-1209. [DOI] [PubMed] [Google Scholar]
- Overstreet J. W., Fuh V. L., Gould J., Howards S. S., Lieber M. M., Hellstrom W., Shapiro S., Carroll P., Corfman R. S., Petrou S. Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol. 1999 Oct;162(4):1295–1300. [PubMed] [Google Scholar]
- Serafini P., Ablan F., Lobo R. A. 5 alpha-Reductase activity in the genital skin of hirsute women. J Clin Endocrinol Metab. 1985 Feb;60(2):349–355. doi: 10.1210/jcem-60-2-349. [DOI] [PubMed] [Google Scholar]
- Walsh P. C., Madden J. D., Harrod M. J., Goldstein J. L., MacDonald P. C., Wilson J. D. Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med. 1974 Oct 31;291(18):944–949. doi: 10.1056/NEJM197410312911806. [DOI] [PubMed] [Google Scholar]